These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6187153)

  • 1. Pemphigus: an epidemiological study of patients treated in Finnish hospitals between 1969 and 1978.
    Hietanen J; Salo OP
    Acta Derm Venereol; 1982; 62(6):491-6. PubMed ID: 6187153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
    Werth VP
    Arch Dermatol; 1996 Dec; 132(12):1435-9. PubMed ID: 8961871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of pemphigus vulgaris by azathioprine and low doses of prednisone (Lever scheme)].
    Benoit Corven C; Carvalho P; Prost C; Verret JL; Saiag P; Noblesse I; Bedane C; Chosidow O; Young P; Roujeau JC; Joly P
    Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 1):13-5. PubMed ID: 12605150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
    Mahajan VK; Sharma NL; Sharma RC; Garg G
    Int J Dermatol; 2005 Oct; 44(10):821-7. PubMed ID: 16207182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of stratifying initial dose of corticosteroids by severity of pemphigus vulgaris on long-term disease severity.
    Lyakhovitsky A; Baum S; Scope A; Amichai B; Barzilai A; Rimer J; Trau H
    Int J Dermatol; 2011 Aug; 50(8):1014-9. PubMed ID: 21781080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid sparing effect of intravenous immunoglobulin therapy in patients with pemphigus foliaceus.
    Sami N; Qureshi A; Ahmed AR
    Eur J Dermatol; 2002; 12(2):174-8. PubMed ID: 11872417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid.
    Gürcan HM; Ahmed AR
    Ann Pharmacother; 2007 Oct; 41(10):1604-10. PubMed ID: 17785614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pemphigus in the Mediterranean region of Turkey: a study of 148 cases.
    Uzun S; Durdu M; Akman A; Gunasti S; Uslular C; Memisoglu HR; Alpsoy E
    Int J Dermatol; 2006 May; 45(5):523-8. PubMed ID: 16700784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of pemphigus in the western region of Turkey: retrospective analysis of 87 patients.
    Bozdag K; Bilgin İ
    Cutan Ocul Toxicol; 2012 Dec; 31(4):280-5. PubMed ID: 22309241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of pemphigus. Critical remarks based on 44 clinical cases].
    Smolle J
    Hautarzt; 1985 Feb; 36(2):96-102. PubMed ID: 2985524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative epidemiology of pemphigus in Tunisia and France. Incidence of foliaceus pemphigus in young Tunisian women].
    Bastuji-Garin S; Souissi R; Blum L; Turki H; Nouira R; Jomaa B; Zahaf A; Ben Osman A; Mokhtar I; Fazaa B; Revuz J; Roujeau JC; Kamoun MR
    Ann Dermatol Venereol; 1996; 123(5):337-42. PubMed ID: 8761089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Post-mortem evaluation in endemic pemphigus foliaceus and pemphigus vulgaris].
    Aki HE; Sotto MN; Sampaio SA
    Med Cutan Ibero Lat Am; 1984; 12(2):151-7. PubMed ID: 6374324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dose, alternate day corticosteroids for systemic onset juvenile rheumatoid arthritis.
    Kimura Y; Fieldston E; Devries-Vandervlugt B; Li S; Imundo L
    J Rheumatol; 2000 Aug; 27(8):2018-24. PubMed ID: 10955346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial.
    Mentink LF; Mackenzie MW; Tóth GG; Laseur M; Lambert FP; Veeger NJ; Cianchini G; Pavlovic MD; Jonkman MF
    Arch Dermatol; 2006 May; 142(5):570-6. PubMed ID: 16702494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A clinical analysis of 64 cases of pemphigus].
    He Z; Wang B; Yu B
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Apr; 20(2):144-7. PubMed ID: 11367721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the rate of long-term complete remission off therapy in patients with pemphigus treated with different regimens including medium- and high-dose corticosteroids.
    Almugairen N; Hospital V; Bedane C; Duvert-Lehembre S; Picard D; Tronquoy AF; Houivet E; D'incan M; Joly P
    J Am Acad Dermatol; 2013 Oct; 69(4):583-8. PubMed ID: 23850258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris.
    Heaphy MR; Albrecht J; Werth VP
    Arch Dermatol; 2005 Jun; 141(6):699-702. PubMed ID: 15967915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment.
    Ahmed AR
    J Am Acad Dermatol; 2001 Nov; 45(5):679-90. PubMed ID: 11606916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The course and prognosis of pemphigus in 47 Tunisian patients.
    Khaled A; Taazayet SB; Ben Alaya N; Souissi A; Zeglaoui F; Kaffel N; Kharfi M; Zermani R; Fazaa B
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):81-5. PubMed ID: 22145661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tunisian pemphigus. Apropos of 70 cases. (Experience of the dermatology department of La Rabta Hospital 1974-1992)].
    Haouet H; Ben Hamida A; Haouet S; Chaffai M; Ben Osman A
    Ann Dermatol Venereol; 1996; 123(1):9-11. PubMed ID: 8734108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.